Rapports

Adcock Ingram Holdings Limited (AIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Rapport
Titre
Adcock Ingram Holdings Limited (AIP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
237.50EUR
Langue
English
Pages
50
Secteur
Santé
Date
Avril 2016
Pays
Afrique du Sud
Type de Produit
Company report
Description du rapport

Adcock Ingram Holdings Limited (Adcock Ingram) is a pharmaceutical company, which develops, distributes and markets of a wide range of healthcare products. The company’s product portfolio includes consumer and over-the-counter (OTC) products; prescription products; and generic medicines. It also provides life-saving hospital equipment, diagnostic products and services. Adcock Ingram provides medicines in the areas of cardiovascular, central nervous system, cough, cold and flu, skin care, diabetes, ear, nose and eye preparations, feminine health, pain and respiratory diseases among others. The company also supplies hospital products, blood systems and accessories used for renal dialysis and transplant medication. It operates three manufacturing facilities, namely, high volume liquids facility, tablet and capsule facility and critical care facility. The company also operates a manufacturing facility in Bangalore, India. Adcock Ingram is headquartered in Midrand, South Africa.

Adcock I

Table des matières

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Adcock Ingram Holdings Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 6

Adcock Ingram Holdings Limited, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 7

Adcock Ingram Holdings Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 8

Adcock Ingram Holdings Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 9

Adcock Ingram Holdings Limited, Medical Devices Deals, 2010 to YTD 2016 11

Adcock Ingram Holdings Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 12

Adcock Ingram Holdings Limited, Pharmaceuticals & Healthcare, Deal Details 14

Asset Purchase 14

Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For US$85 Million 14

Adcock Ingram Acquires ADDvance Brand From Peppina Sales 16

Private Equity 17

Actis Rumored To Acquire Adcock Ingram For US$1.25 Billion 17

Partnerships 18

EffRx Pharma Enters into Distribution Agreement with Adcock Ingram Healthcare for Binosto 18

Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 19

Adcock Ingram Holdings Expands Its Distribution Agreement With Merck 20

Adcock Ingram Enters Into Co-Promotion And Distribution Agreement With Merck 21

Adcock Ingram Enters Into Agreement With Lilly 23

Asset Transactions 24

Adcock Ingram Completes Acquisition Of Portfolio Of Drugs From Cosme Farma Labs For US$85 Million 24

Acquisition 26

Adcock Ingram May Divest Indian Business 26

Carlyle, Kedaara and Other PE Firms May Acquire Cosme Farma 27

Adcock Ingram Rejects Acquisition Offer for Remaining 65.5% Stake from Bidvest Group 28

Ascendis Health to Acquire Majority Stake in Scientific Group for USD26 Million 30

Public Investment Acquires Additional 3.17% Stake In Adcock Ingram 31

CFR Pharma Terminates USD1.2 Billion Acquisition of Adcock Ingram 32

BB Investment Acquires 32.03% Stake In Adcock Ingram 34

Bidvest And Community Investment Complete Acquisition Of 34.5% Stake In Adcock Ingram For US$393 Million 35

Bidvest Acquires Additional 2.2% Stake In Adcock Ingram From Oasis 37

Foord Asset Management Acquires Additional 4.81% Stake In Adcock Ingram 38

Public Investment Acquires Additional 3.47% Stake In Adcock Ingram 39

Adcock Ingram Completes Acquisition Of Nutrilida Healthcare 40

Adcock Ingram Acquires Remaining 49% Stake In AddClin Research From Synexus 41

Adcock Ingram Acquires 51% Stake In Bio Swiss 42

Adcock Ingram Holdings To Acquire A Pharma Company In West Africa 43

Adcock Ingram Acquires 65.59% Stake In Ayrton Drugs 44

Adcock Ingram Holdings Limited - Key Competitors 46

Key Employees 47

Locations And Subsidiaries 49

Head Office 49

Other Locations & Subsidiaries 49

Appendix 50

Methodology 50

About GlobalData 50

Contact Us 50

Disclaimer 50

Description de l'éditeur

GlobalData is the premier source of actionable insight into the healthcare industry. With the combined expertise of more than 1,000 researchers, market analysts and consultants, we provide high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

Combining precision with innovation, our research and consulting solutions ensure our clients stay at the forefront of their markets by integrating accurate market forecasts and analysis on the latest trends and developments with the unrivalled expertise of our analyst teams. Among other benefits, our informed industry perspectives help clients understand how to generate the maximum return from their key markets, identify opportunities from emerging trends, and devise strategies for growth with confidence.

 

Contact:  Partner Supportpartnersupport@globaldata.com

                 Sunil Sethia ssethia@globaldata.com